Propofol Market Evolving Technology, Trends, Key market segments and industry Analysis by 2022

Global Propofol Market expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Propofol is the generic name for Diprivan an injectable drug, which fits a class of medications called as anesthetics or hypnotics. A drug decreases nervousness and tension, used to put people sleep before surgery, and promotes loss of consciousness. Hypnotics helps by reducing the movement of a pain by messaging the nerves. It is chemically termed as 2, 6-di-isopropyl phenol. For general anesthesia, the induction dose is around 2mg/kg.

Propofol inclusively used during diagnostic tests and surgical procedures and given for drowsiness in hospital intensive care units (ICUs) to reduce awareness and cause sleep for adults who are being treated. Food and Drug Administration (FDA) approve the drug. It is an intravenous anesthetic agent used for induction and maintenance of general anesthesia. It mainly excluded by hepatic conjugation to inactive metabolites that evacuated by the kidney. Propofol is existing as an injection and appropriate for intravenous injection given by highly trained healthcare professionals like critical-care nurses and anesthesiologists. In addition, also be administered through an infusion pump set up to deliver a target-controlled infusion (TCI). It is water soluble and expressed in a white, oil-in-water suspension. It also known to show an activity of the brain and nervous system. 


Propofol Market segmented based on product type, application, and region. Product type into Liquid and Powder classify Propofol Market. Application into Medical Uses, Clinical Applications, and others classify Propofol Market. Propofol Market segmented, geographically into America (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa. The key players of Propofol Market are Bachem, AstraZeneca, Piramal Critical, Fresenius Kabi, Jiangsu Nhwa, B.Braun Melsungen, Guangdong Jiabao, Hospira, Sichuan Guorui and Xi'an Libang.


Comments